Stanford researchers have designed a method to increase the photoyield of thin film CsBr/metal photocathodes by activation with electron bombardment, allowing efficient operation at UV and longer incident light wavelengths.
Stanford researchers have invented a fully water-soluble, orange hydrazine sensor that can robustly quantify the toxin hydrazine in liquids such as drinking water, waste water (treated and untreated), and bodily fluids.
Researchers in Prof. Irving Weissman's laboratory have developed cell culture techniques to rapidly and efficiently derive pure populations of mesodermal cells from human pluripotent stem cells (hPSCs).
Researchers in Dr. Jianghong Rao's lab have developed nanoprobes for monitoring drug-induced hepatotoxicity in vivo in real time. Drug toxicity is a long-standing concern of modern medicine.
Researchers at Stanford have engineered proteins to selectively sensitize T cells to IL-2. The ability to manipulate immune cells for therapeutic use is of great clinical interest. Cytokines are signaling molecules that can be used to alter cellular behavior.
Researchers in Prof. Karen Parker's laboratory have discovered a biomarker that could enable an objective laboratory-based test for diagnosing autism spectrum disorders (ASD) and predicting the severity of a patient's symptoms.
Researchers at Stanford have developed methods using click chemistry to immobilize and concentrate therapeutic factors on a tissue to improve wound healing.
Researchers in Prof. Lei Xing's laboratory have developed a radioluminescent platform to combine molecular and X-ray imaging using standard X-ray equipment coupled with a photodetector.
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
Researchers in the Stanford Genome Technology Center have developed a robust, high-throughput, high-efficiency functional genomics platform to generate precisely edited genome variant libraries and then readily isolate and identify thousands of individual strains en masse
Stanford researchers at the Pratx Lab have developed a new trajectory reconstruction method for tracking moving sources labeled with positron-emitting radionuclides using PET.
Stanford researchers in the Blau Lab have discovered that telomere length can be used as a biomarker for cardiomyopathy diagnosis and drug screening with cardiomyocytes.
Researchers at Stanford have developed methods to enhance bone healing in diabetic patients, who often suffer from impaired fracture healing due to a deficiency in hedgehog signaling in their skeletal stem cells.